Capricor Therapeutics
Capricor Therapeutics is providing CAP-1002, its novel cell therapy to patients with advanced COVID-19 under the compassionate use pathway
Rankings by
Национальный рейтинг235th
in United States Региональный рейтинг262nd
in North America and Caribbean Глобальный рейтинг646th
worldwide